Page last updated: 2024-09-05

sorafenib and dicumarol

sorafenib has been researched along with dicumarol in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(dicumarol)
Trials
(dicumarol)
Recent Studies (post-2010) (dicumarol)
6,5207305,2512,26033110

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)dicumarol (IC50)
CholinesteraseHomo sapiens (human)0.0026
Cytochrome P450 2C9 Homo sapiens (human)0.3
NADHomo sapiens (human)0.2585
Mitogen-activated protein kinase 1Homo sapiens (human)4.426
Proprotein convertase subtilisin/kexin type 7Homo sapiens (human)1.3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Luo, J; Mu, X; Wang, Z; Yang, Q; Zhao, Y1

Other Studies

2 other study(ies) available for sorafenib and dicumarol

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha.
    Journal of colloid and interface science, 2022, Dec-15, Volume: 628, Issue:Pt B

    Topics: Antineoplastic Agents; Aspartic Acid; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Cytochromes c; Dicumarol; Female; Glutathione; Humans; Hypoxia; Micelles; NAD; NADP; Nitroimidazoles; Oxygen; Phosphates; Polyethylene Glycols; Polymers; Quinones; Sorafenib; Thioredoxins

2022